These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18839433)

  • 1. Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma.
    Marabelle A; Sapin V; Rousseau R; Periquet B; Demeocq F; Kanold J
    Pediatr Blood Cancer; 2009 Feb; 52(2):280-3. PubMed ID: 18839433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.
    Villablanca JG; Khan AA; Avramis VI; Reynolds CP
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):410-5. PubMed ID: 8214363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma.
    Cross SF; Dalla Pozza L; Munns CF
    Pediatr Blood Cancer; 2009 Oct; 53(4):666-8. PubMed ID: 19492317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma.
    Chen SC; Murphy D; Sastry J; Shaikh MG
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):477-81. PubMed ID: 26056798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
    Villablanca JG; Khan AA; Avramis VI; Seeger RC; Matthay KK; Ramsay NK; Reynolds CP
    J Clin Oncol; 1995 Apr; 13(4):894-901. PubMed ID: 7707116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma.
    Belden TL; Ragucci DP
    Pharmacotherapy; 2002 May; 22(5):645-8. PubMed ID: 12013365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia induced by 13 cis-retinoic acid in patients with neuroblastoma.
    Mugishima H; Chin M; Suga M; Schichino H; Ryo N; Nakamura M; Harada K
    Pediatr Int; 2008 Apr; 50(2):235-7. PubMed ID: 18353067
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.
    Kohler JA; Imeson J; Ellershaw C; Lie SO
    Br J Cancer; 2000 Nov; 83(9):1124-7. PubMed ID: 11027423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral treatment with retinoic acid decreases bone mass in rats.
    Hotchkiss CE; Latendresse J; Ferguson SA
    Comp Med; 2006 Dec; 56(6):502-11. PubMed ID: 17219781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of advanced bone age in a cohort of patients who received cis-retinoic acid for high-risk neuroblastoma.
    Hobbie WL; Mostoufi SM; Carlson CA; Gruccio D; Ginsberg JP
    Pediatr Blood Cancer; 2011 Mar; 56(3):474-6. PubMed ID: 21072832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy.
    Gyorfy A; Kovács T; Szegedi I; Oláh E; Kiss C
    Med Pediatr Oncol; 2003 Feb; 40(2):135-6. PubMed ID: 12461805
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypercalcemia associated with tumors in children. 20 cases].
    Leblanc A; Hartmann O; Pons G; Caillaud JM; Couanet D; Lenoir G; Lemerle J
    Arch Fr Pediatr; 1984 Oct; 41(8):551-5. PubMed ID: 6508484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13-cis retinoic acid and isomerisation in paediatric oncology--is changing shape the key to success?
    Armstrong JL; Redfern CP; Veal GJ
    Biochem Pharmacol; 2005 May; 69(9):1299-306. PubMed ID: 15826600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN
    Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacogenetics of 13-cis-retinoic acid in the treatment of neuroblastoma.
    Veal G; Rowbotham S; Boddy A
    Therapie; 2007; 62(2):91-3. PubMed ID: 17582307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.
    Khan AA; Villablanca JG; Reynolds CP; Avramis VI
    Cancer Chemother Pharmacol; 1996; 39(1-2):34-41. PubMed ID: 8995497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13-cis-retinoic acid-associated bone marrow edema in neuroblastoma.
    Sato Y; Kuwashima S; Kurosawa H; Sugita K; Fukushima K; Arisaka O
    Pediatr Blood Cancer; 2012 Sep; 59(3):589-90. PubMed ID: 22354520
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercalcemia is a frequent side effect of 13-cis-retinoic acid treatment in patients with high-risk neuroblastoma.
    Hoemberg M; Schwenzfeur R; Berthold F; Simon T; Hero B
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29374. PubMed ID: 34569150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.
    Finklestein JZ; Krailo MD; Lenarsky C; Ladisch S; Blair GK; Reynolds CP; Sitarz AL; Hammond GD
    Med Pediatr Oncol; 1992; 20(4):307-11. PubMed ID: 1608352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma.
    Steineck A; MacKenzie JD; Twist CJ
    Pediatr Blood Cancer; 2016 Nov; 63(11):2050-3. PubMed ID: 27399265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.